Last updated
QuidelOrtho: Ma Activity
QuidelOrtho plans to divest its testing unit for $1.5 billion
Source: Seeking Alpha — Market Currents
The leadership read
Consolidation of this kind shifts demand toward integration and transformation leadership bench strength in medtech.
Market context: The wider read — a Talent Market Index of 113.9 (Hot), up 13.8 month-on-month — shows Americas signal flow easing (-3pts).
QuidelOrtho: 1 signal in the last 90 days — in line with the MedTech median of 1 across 19 tracked companies; 0.1% of MitchelLake's Americas signal flow; 2 tracked across 95 days.
Also at QuidelOrtho →
More signals across MedTech
Ma Activity · Americas
Medtronic →Medtronic completed a $550M acquisition of Scientia Vascular, expanding its vascular intervention and treatment capabilities
Ma Activity · Americas
Analog Devices →In talks to acquire Empower Semiconductor for $1.5 billion, focusing on AI chip power management
Ma Activity · Americas
Boston Scientific →Boston Scientific invested $1.5bn to acquire a 34% equity stake in MiRus, an implants and procedural solutions developer
Ma Activity · Americas
QuidelOrtho Corporation →QuidelOrtho Corporation completed acquisition of LEX Diagnostics, expanding into point-of-care molecular diagnostics with ultra-fast PCR platform delivering results in ~10 minutes
Ma Activity · Americas
Abbott →Abbott completed acquisition of Exact Sciences, establishing itself as a leader in the fast-growing oncology diagnostics market
Leadership Change · Americas
Illumina →Illumina appoints Daniel M. Skovronsky, Chief Scientific and Product Officer at Eli Lilly and President of Lilly Research Laboratories, to its Board of Directors, effective June 16, 2026.
Intelligence powered by Autonodal ↗